Gooch & Housego's FY25 trading update showcases resilience with defence-led growth, a robust order book, and strategic acquisitions.
This article covers information on Gooch u0026 Housego PLC.
LON:GHHGooch & Housego (AIM: GHH) has delivered a solid full-year trading update for the 12 months to 30 September 2025. Momentum from the first half carried through H2, even with the familiar mix of macroeconomic and geopolitical bumps in the road.
The headline: revenues and adjusted profit before tax (adjusted PBT) are expected to be broadly in line with the Board’s expectations, albeit with moderately higher non-underlying costs from acquisitions and restructuring. The full results will land on 2 December 2025.
Industrial revenues were mixed. Fibre optic couplers and modules used in subsea data networks grew well, counterbalancing broadly flat sales to industrial laser customers. Management notes early signs of a semiconductor recovery, but the near term remains unpredictable due to supply chain and tariff issues.
My take: subsea demand feels structurally supported by global data traffic and cable investment, which is a handy hedge while lasers and semis find their feet. Customer activity picked up towards year-end, which is encouraging for FY26.
Life Sciences sales benefited from customer phasing of several medical diagnostic programmes in Ashford, Kent. G&H also saw a positive response to a “last time buy” notice for its Pockels Cells used in medical lasers. Deliveries will run through the coming year, after which the Cleveland, Ohio site will shift capacity to crystals for broader optical applications.
Quick explainer: Pockels Cells are electro-optic devices used to precisely control laser beams. A last time buy is when a company ends production but offers customers a final chance to purchase.
Aerospace & Defence delivered further revenue growth in H2, driven by strong demand for precision optics and advanced sighting and imaging systems on military platforms. Commercial aerospace remains supportive too, with healthy demand for ring laser gyro components.
Operational improvements and extra capacity added over the last couple of years are paying off here. This is the engine room of growth right now and looks set to stay that way into FY26.
Integration is “proceeding to plan” for both Phoenix Optical and Global Photonics, acquired during FY25. The strategy is about speed to value within Aerospace & Defence, and there are already tangible signs:
Customer feedback has been positive, and G&H is pursuing a number of new opportunities. If these convert, they should underpin the order book and mix in FY26.
The order book continues to trend up and provides useful visibility for the new year. Over 80% of it is for delivery in FY26, including the full-year impact of the acquisitions.
Net bank debt (excluding IFRS 16 leases) has increased, reflecting acquisitions and investment in inventory alongside solid underlying cash generation before non-underlying items. That is a deliberate choice to support delivery and growth, but it will put a spotlight on cash conversion in FY26.
| Key numbers | FY25 | Comparatives |
|---|---|---|
| Order book (30 Sep 2025) | £142.3m | £121.5m (31 Mar 2025); £104.5m (30 Sep 2024) |
| Net bank debt excl. IFRS 16 (30 Sep 2025) | £30.0m | £24.1m (31 Mar 2025); £16.0m (30 Sep 2024) |
| FY25 revenues | Broadly in line with expectations | Board expectations not disclosed |
| FY25 adjusted PBT | Broadly in line with expectations | Board expectations not disclosed |
| Delivery profile | Over 80% of order book for FY26 | – |
| Results date | 2 December 2025 | – |
Management highlights operational improvements, proactive supply chain handling, targeted investment to enhance capability, and the capitalisation of overheads in inventory. Capitalising overheads means some production costs are carried on the balance sheet as inventory rather than expensed immediately, which can flatter near-term margins but reverses when the inventory is sold.
Non-underlying costs are set to be “moderately higher” due to acquisitions and restructuring. Adjusted PBT excludes such non-underlying items as well as amortisation of acquired intangibles and impairments. The underlying operational progress looks genuine, but the statutory P&L will carry more one-offs in FY25.
The order book and recent acquisitions underpin increased trading in FY26, partially offset by higher overheads. Aerospace & Defence demand is described as strong across the UK, USA and Europe. Industrial and Life Sciences face a subdued near-term outlook, with recovery timing uncertain due to supply chain and tariff challenges.
Semiconductors are showing early green shoots, with management expecting modest growth in the medium term. Given photonics is a key enabler in advanced semiconductor equipment, that could provide a useful tailwind if it broadens out in calendar 2026.
This is a reassuring update. G&H delivered steady trading, expanded its order book, and is leaning into Aerospace & Defence with two well-targeted acquisitions. The price is higher non-underlying costs and a step up in net debt, but the strategic direction looks sound and supported by growing demand where it matters.
If the Industrial and Life Sciences recovery emerges through FY26 and semiconductor demand improves as expected, the company should have multiple levers for growth. For now, defence strength and order book visibility do the heavy lifting.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
59 viewsLikes
No ratings yet
No comments yet - start the conversation.